Skip to content
Menu

BTIG Maintains Buy on Astrana Health, Raises Price Target to $65

Benzinga Newsdesk 4 months ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BTIG analyst David Joyce maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $50 to $65.

BTIG analyst David Joyce maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $50 to $65.

Read at benzinga.com